California-based firm OpenAI is expanding access to its life sciences AI model for select government and allied partners, marking a new step forward in the use of artificial intelligence for biodefense and biological threat preparedness.
The initiative is part of the company’s newly launched biodefense program, which provides trusted organizations with access to GPT-Rosalind, a specialized AI tool designed for life sciences research.
The program is intended to support missions such as outbreak modeling, early threat detection, preparedness planning, and the development of medical countermeasures.
Read the rest of the story at Military AI.
